AstraZeneca PLC
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy AstraZeneca PLC stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for AstraZeneca PLC by name or ticker, choose the number of shares, and place your order.
The ticker symbol for AstraZeneca PLC is AZN:xlon. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
AstraZeneca PLC has its primary listing on London Stock Exchange. You can trade AstraZeneca PLC with a Saxo account, alongside thousands of other stocks worldwide.
Yes, AstraZeneca PLC is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include AstraZeneca PLC as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like AstraZeneca PLC.